Lithuania vs Uzbekistan: Hepatitis B surface antigen (HBsAg) prevalence
Lithuania
0.1%
in 2024
Uzbekistan
0.1%
in 2024
Lithuania rank
101st
Uzbekistan rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Lithuania
- Uzbekistan
How they compare
Lithuania currently reports 0.1% against 0.1% in Uzbekistan, a difference of 0.0%.
Across all 10 years both countries report, Uzbekistan has been ahead every year.
Lithuania ranks 101st and Uzbekistan ranks 101st of 194 countries.
Head to head by decade
| Decade | Lithuania | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Lithuania or Uzbekistan?
- Lithuania, at 0.1% against 0.1% in Uzbekistan as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Lithuania and Uzbekistan?
- 0.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Uzbekistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Lithuania and Uzbekistan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Lithuania ranks 101st and Uzbekistan ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.